Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-20

Clinical Trial Update: Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dose adjustment from levothyroxine to a new levothyroxine sodium test formulation has completed and reported results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)

Snippet

Sponsor: Takeda | Conditions: Hypothyroidism | Phase 2 | Status: COMPLETED | Results posted: 2015-07-20